drugset
Drugs / Enriched Hematopoetic Stem Cell Infusion
last change Aug 2013 re-read 3 minutes ago

Enriched Hematopoetic Stem Cell Infusion

Cell therapy

Developed for
sickle cell disease
Investigated by
Duke University · Hahnemann University Hospital · Medical College of Pennsylvania Hospital · St. Christopher's Hospital for Children · Talaris Therapeutics Inc. · The Western Pennsylvania Hospital
+1 more · University of Florida

Trials 1

today NCT00777231 · Ph 1/2
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00777231 Jan 2005 → Aug 2010 sickle cell disease Talaris Therapeutics Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Enriched Hematopoetic Stem Cell Infusion ClinicalTrials.gov intervention name — accepted as the source's own label NCT00777231 ↗
Modality Cell therapy “Enriched Hematopoetic Stem Cell Infusion” NCT00777231 ↗